openPR Logo
Press release

Venous Skin Ulcer Treatment Market : Lucrative Opportunities

03-01-2022 05:18 PM CET | Health & Medicine

Press release from: Transparency Market Research

Venous Skin Ulcer Treatment Market: Introduction

According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings, negative pressure wound therapy, and medications. Negative pressure wound therapy involves continuous or intermittent application of sub-atmospheric pressure to the wound dressing system, which provides a positive pressure to the surface of a wound. Some advanced therapies also include skin substitutes, which are tissue engineered skin substitutes made of cells, extracellular matrix, and combination of cells & matrices. These are mostly employed in the treatment of burns, diabetic ulcers, vascular ulcers, and lacerations. North America dominated the global venous skin ulcer treatment market in 2019. It is expected to maintain its dominance, in terms of value, by the end of 2030.

Request a Sample of Venous Skin Ulcer Treatment Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77547

Increase in Prevalence & Incidence of Venous Leg Ulcer to Drive Market

Immobility, varicose veins, obesity, pregnancy, and previous deep vein thrombosis are major factors responsible for the development of venous leg ulcers. Consequently, prevalence and incidence of venous leg ulcers is rising rapidly. Increase in prevalence and incidence of venous leg ulcer is estimated to boost the global venous skin ulcer treatment market. For instance, as per an article published by the National Center for Biotechnology Information (NCBI), the prevalence of venous leg ulcers in the U.S. is around 600,000 annually. The rise in geriatric population and increase in adoption of technologically advanced wound care products are also key factors that drive the global venous skin ulcer treatment market.

The availability of different skin substitutes and rise in patient awareness and healthcare expenditure are major factors that further propel the global venous skin ulcer treatment market.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77547

Negative Pressure Wound Therapy to be in High Demand

Based on product, the global venous skin ulcer treatment market has been classified into compression therapy, advanced wound dressings, negative pressure wound therapy, skin grafts & substitutes, medications, and others. The compression therapy segment has been further bifurcated into compression bandages and compression hosiery. The compression therapy segment accounted for a major share of the global venous skin ulcer treatment market in 2019, due to new product launches and higher demand following its features such as better therapeutic effects. Negative pressure wound therapy is a highly promising segment and it is projected to expand at a higher CAGR during the forecast period, owing to rapid healing and decline in the number of dressing changes and risk of pathogenic infection.

Request for Analysis of COVID19 Impact on Venous Skin Ulcer Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77547

Stage IV Dominated Global Market

In terms of stage, the global venous skin ulcer treatment market has been segmented into stage I, stage II, stage III, and stage IV. The stage IV segment accounted for a major share of the global venous skin ulcer treatment market in 2019. It is also estimated to expand at a higher CAGR during the forecast period. Long-term management treatment and higher cost of treatment associated with severe form of disease are key factors fueling the stage IV segment.

Home Care Settings to be Promising End User
Based on end user, the global venous skin ulcer treatment market has been divided into hospitals & clinics, long-term care facilities, home care settings, and others. The hospitals & clinics segment has been further split into inpatient settings and outpatient settings. The hospitals & clinics segment held a prominent share of the global venous skin ulcer treatment market in 2019, due to a high number of hospital admissions and better reimbursement facilities provided by hospitals. The home care settings segment is projected to expand at a notable CAGR during the forecast period, owing to an increase in the geriatric population and improvement in healthcare infrastructure and support facilities.

North America to Lead Global Market
In terms of region, the global venous skin ulcer treatment market has been divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global venous skin ulcer treatment market in 2019, owing to rising prevalence of chronic wounds, better reimbursement scenario, and early adoption of advanced products in the region. For instance, as per Centers for Disease Control and Prevention (CDC) estimates, around 2.5 million patients suffer from pressure ulcers every year in the U.S. The market in Asia Pacific is estimated to expand at a prominent CAGR during the forecast period, owing to an increase in geriatric population, emergence of strong local manufacturers offering technologically advanced products at lower prices, and a rise in awareness among people about early diagnosis of chronic wounds.

Enquiry before Buying Venous Skin Ulcer Treatment Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=77547

Competition Landscape

The global venous skin ulcer treatment market is fragmented in terms of number of players with entry of several emerging new players in the market. Key players in the global market include Smith & Nephew plc., Integra LifeSciences Corporation, Mölnlycke Health Care AB, Cardinal Health, 3M, URGO Medical, Bauerfeind, PAUL HARTMANN AG, and SIGVARIS. Research collaborations, mergers, acquisitions & strategic collaborations, and new product & technology launches in recent years are key strategies adopted by major companies operating in the global venous skin ulcer treatment market.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/rise-in-the-demand-for-personalized-medicines-to-propel-the-drug-discovery-outsourcing-market-says-tmr-301326948.html

https://www.prnewswire.com/news-releases/rising-demand-for-needle-free-vaccines-to-drive-innovation-in-the-respiratory-virus-vaccines-market-tmr-301332746.html

https://www.prnewswire.com/news-releases/surgical-microscopes-market-revenue-to-reach-us-1-3-billion-by-2027--manufacturers-focus-on-performance-and-portability-of-products-for-innovation-transparency-market-research-301336425.html

Contact Us

Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Skin Ulcer Treatment Market : Lucrative Opportunities here

News-ID: 2567451 • Views:

More Releases from Transparency Market Research

Materials for Electric Vehicle Charging Infrastructure Market Size Expected to Hit USD 18.1 billion by 2034 with a 32.7% CAGR Increase | Transparency Market Research Inc.
Materials for Electric Vehicle Charging Infrastructure Market Size Expected to H …
The market for materials used in electric vehicle (EV) charging infrastructure is expanding rapidly, driven by the global shift toward electric mobility and the increasing need for widespread charging networks. This market encompasses materials used in the production of charging stations, cables, connectors, enclosures, and related components, ensuring reliability, efficiency, and durability. Key materials include metals, polymers, semiconductors, and composite materials. As the adoption of electric vehicles accelerates, the demand for
Silylated Polymers Market is Anticipated to Reach USD 1.6 Billion by 2034, Growing at a CAGR of 5.5%: Transparency Market Research, Inc
Silylated Polymers Market is Anticipated to Reach USD 1.6 Billion by 2034, Growi …
The Silylated Polymers market is experiencing robust growth due to their versatility and superior performance in adhesives, sealants, and coatings. Silylated polymers, also known as silane-terminated polymers, combine the benefits of silicone and organic polymers, offering excellent adhesion, elasticity, and weather resistance. These materials are increasingly adopted in construction, automotive, and industrial applications for their durability and eco-friendly properties. Silylated polymers are advanced materials where silane groups are chemically bonded to
1,3-Butadiene Market Poised to Reach USD 73.6 Billion by 2034 with 6.0% CAGR: Exclusive Report by Transparency Market Research Inc.
1,3-Butadiene Market Poised to Reach USD 73.6 Billion by 2034 with 6.0% CAGR: Ex …
The 1,3-Butadiene market is a key segment of the petrochemical industry, driven by its extensive applications in producing synthetic rubber, plastics, and other chemicals. Derived from the cracking of hydrocarbons, 1,3-Butadiene is a vital raw material for industries such as automotive, construction, and electronics. The market's growth is closely tied to global industrial and manufacturing activities. 1,3-Butadiene is an unsaturated hydrocarbon and a significant building block in the chemical industry. Its
At a CAGR of 5.0%, Paint Remover Market is Anticipated to Reach USD 1.8 billion by 2034: Transparency Market Research, Inc
At a CAGR of 5.0%, Paint Remover Market is Anticipated to Reach USD 1.8 billion …
The paint remover market is experiencing steady growth, driven by its use across construction, automotive, furniture restoration, and industrial applications. Paint removers, or paint strippers, are chemical or eco-friendly solutions designed to remove old paint, coatings, or finishes from surfaces like wood, metal, or masonry. Increasing demand for efficient and environmentally friendly products is shaping the market dynamics. Paint removers play a vital role in renovation, repair, and maintenance activities. They

All 5 Releases


More Releases for Venous

Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism. Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188 Pulmonary embolism occurs in almost one-third of patients
Venous Thromboembolism Treatment Market Analysis by 2028
Global Venous Thromboembolism Treatment Market: Overview When a blood clot is stuck in a vein is known as venous thromboembolism (VTE), this block the flow of blood to the other parts. A person facing this situation requires immediate medical attention. According to various studies, venous thromboembolism is considered as a third leading cause for vascular diagnosis after heart attack and stroke. There are about 300,000 to 600,000 individuals facing
Venous Syringe Market Size, Share, Development by 2025
Market Research Report Store offers a latest published report on Venous Syringe Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Venous Syringe players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/1021886/global-venous-syringe-market-insights The
Continuous Renal Replacement Therapy (CRRT) Market Report 2018: Segmentation by …
Global Continuous Renal Replacement Therapy (CRRT) market research report provides company profile for Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, NxStage Medical, Inc., Nipro Corporation, NIKKISO CO., LTD., Toray Medical Company Limited, INFOMED SA and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018
Venous Thromboembolism Market - Global Industry Analysis 2025
According to the International Society on Thrombosis and Haemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood clots in vein. If the clot is in deep vein (usually leg), it is called as deep vein thrombosis, while a clot in lungs is termed as pulmonary embolism. Request to download and
Rise in Incidence Rate of Venous Thromboembolism is Fueling the Venous Thromboem …
Venous thromboembolism (VTE) is the formation of blood clots inside the blood vessel. These clots restrict blood flow through the circulatory system. It is classified into two type’s deep vein thrombosis and pulmonary embolism. Formation of blood clot in a deep vein (generally in the leg) is called deep vein thrombosis. The formed deep vein thrombosis clot break off and travels to the lungs, called as pulmonary embolism. Pulmonary embolism